Viridian Therapeutics

$14.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.91 (-5.92%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell VRDN and other stocks, options, and ETFs commission-free!

About VRDN

Viridian Therapeutics, Inc. Common Stock, also called Viridian Therapeutics, is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics.

CEO
Jonathan Violin
Employees
27
Headquarters
Boulder, Colorado
Founded
2006
Market Cap
111.07M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
25.26K
High Today
$15.66
Low Today
$14.36
Open Price
$15.25
Volume
43.25K
52 Week High
$25.67
52 Week Low
$7.08

VRDN Earnings

-$5.31
-$3.54
-$1.77
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, After Hours

You May Also Like

STRR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure